NASDAQ: VINC - Vincerx Pharma, Inc.

半年間の収益性: -73.68%
配当利回り: 0.00%
セクタ: Healthcare

プロモーションスケジュール Vincerx Pharma, Inc.


会社について Vincerx Pharma, Inc.

Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. It is developing enitociclib, a cyclin-dependent kinase-9 inhibitor that is in Phase 1 clinical trials for treating patients with hematologic malignancies; and VIP236, a small molecule drug conjugate that is in Phase 1 clinical trials to treat solid tumors. The company's preclinical stage product candidates include VIP943 and VIP924 for the treatment of hematologic malignancies. Vincerx Pharma, Inc.

さらに詳しく
was founded in 2019 is based in Palo Alto, California.

IPO date 2020-05-27
ISIN US92731L1061
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://vincerx.com
Цена ао 5.12
1日あたりの価格変動: +5.49% (0.1839)
週ごとの価格変動: -6.33% (0.2071)
月ごとの料金変更: -26.52% (0.264)
3ヶ月間の価格変動: -71.68% (0.685)
半年間の価格変動: -73.68% (0.737)
年間の価格変動: -83.56% (1.18)
3年間の価格推移: -98.06% (10)
5年間の価格推移: +0% (0.194)
10年間の価格推移: +0% (0.194)
年初からの価格変動: -24.22% (0.256)

過小評価

名前 意味 学年
P/S 0 0
P/BV 1.75 8
P/E 0 0
EV/EBITDA -0.2216 0
合計: 3.5

効率

名前 意味 学年
ROA, % -220.44 0
ROE, % -357.84 0
合計: 0

配当金

名前 意味 学年
Div yield, % 0 0
DSI 0 0
合計: 0

義務

名前 意味 学年
Debt/EBITDA -0.06 10
合計: 10

成長の衝動

名前 意味 学年
収益性 Revenue, % 0 0
収益性 Ebitda, % 94586.67 10
収益性 EPS, % 21575.26 10
合計: 8



スーパーバイザー 役職 支払い 生年
Dr. Ahmed M. Hamdy M.D. Co-Founder, Chairman & CEO 657.54k 1965 (60 年)
Dr. Raquel E. Izumi Ph.D. Co-Founder, President, COO, Secretary & Director 591.54k 1970 (55 年)
Mr. Alexander A. Seelenberger M.B.A. Chief Financial Officer 491.69k 1979 (46 年)
Mr. Tom C. Thomas J.D. Founder, General Counsel & Chief Legal Officer 444.14k 1960 (65 年)
Dr. John C. Byrd M.D. Founder & Chairman of Scientific Advisory Board N/A
Dr. Hans-Georg Lerchen Ph.D. Chief Scientific Officer N/A
Ms. Gabriela Jairala Vice President of Investor Relations & Corporate Communications and Chief of Staff N/A
Ms. Melissa Merrick SPHR Senior Director of People & Culture and Head of Human Resource N/A
Dr. Beatrix Stelte-Ludwig Ph.D. Executive Chief Development Officer N/A
Ms. Karen Quarford M.B.A. Vice President of Quality Operations & Compliance

住所: United States, Palo Alto. CA, 260 Sheridan Avenue - Googleマップで開く, Yandexマップを開く
Webサイト: https://vincerx.com